Mkts

Amneal Pharmaceuticals, Inc.

NASDAQ: AMRX
$21.38+0.10 (+0.47%)
As of Nov 10, 4:00 PM ET

Key statistics

Day range
21.0221.63
52-week range
11.2921.68
Today
Open21.28
Previous close21.38
Volume—
Valuation
Market cap7.48B
P/E ratio56.12×
EPS (TTM)0.41
Income & risk
Dividend / yield—
Beta1.20
Avg volume2.77M
Discussion

AMRX News

Stories mentioning AMRX from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue722,519814,319784,513724,508695,420730,518702,468701,780
Cost of Goods Sold402,406517,129510,539438,255439,529467,645432,910451,833
Gross Profit320,113297,190273,974286,253255,891262,873269,558249,947
Operating Expenses
Research & Development38,38334,81963,35247,96440,04054,26561,09736,054
Sales General & Admin138,860146,458137,815124,266118,288128,687118,692116,462
Total Operating Expenses
Operating Income (Loss)141,772112,03370,344111,372100,34775,79388,80995,470
Interest Income
Interest Expense
Other Expense742.0013,1651,2351,604518.002,1721,1784,360
Pretax Income80,17655,235(5,223)51,71137,486(15,319)15,42320,405
Tax Provision2,1765,662(23,355)16,10112,8685,4233,6663,618
Net Income (Loss)62,25635,0762,36922,41712,195(31,081)(156.00)5,994
Earnings Per Share (Basic)0.200.110.010.070.04(0.10)0.000.02
Earnings Per Share (Diluted)0.190.110.010.070.04(0.10)0.000.02
Weighted Average Shares Outstanding (Basic)316,023313,367314,168313,739311,054308,978309,647309,117
Weighted Average Shares Outstanding (Diluted)328,933324,805324,754322,363323,961308,978309,647318,957

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About AMRX

Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) is a stock listed on the Nasdaq Stock Market under the ticker symbol AMRX. It last traded at $21.38 (Nov 10, 2026, 4:00 PM ET), up 0.5% on the day. That gives Amneal Pharmaceuticals a market capitalisation of $7.5B and a price-to-earnings ratio of 56.1.

Over the past 52 weeks AMRX has traded between $11.29 and $21.68.

Revenue for the quarter ended Mar 31, 2026 was $722.5M; net income $62.3M. Revenue was up 3.9% from $695.4M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$722.5M$62.3M8.6%
Dec 31, 2025$814.3M$35.1M4.3%
Sep 30, 2025$784.5M$2.4M0.3%
Jun 30, 2025$724.5M$22.4M3.1%

From Amneal Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…